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The median age of survival in patients with cystic fibrosis (CF) has improved considerably. Despite this 
improvement, deterioration of pulmonary function and decrease in exercise capacity are still the main 
problems for many patients. Although dyspnoea is a common complaint in CF patients, relatively little 
regard has been paid to this symptom. This study examined the relationship between dyspnoea, bicycle 
exercise capacity and pulmonary function in patients with CF. 
In 14 patients in a stable clinical condition, pulmonary function [forced expiratory volume in 1 s 
(FEV,), inspiratory vital capacity (IVC)], bicycle exercise capacity [maximum exercise capacity ( Wmax)], 
subjective degree of dyspnoea during daily living [Medical Research Council (MRC) dyspnoea scale], 
and during exercise (Borg scale) were assessed. 
The mean (SD) age of the patients was 25 (6.8) years, FEV, was 41 (19)% predicted, IVC was 63 (17)% 
predicted and FEV,/IVC ratio was 47 (lo)%; median (range) Wmax was 55 (O-79)% predicted. Bicycle 
exercise test performance appeared to be mainly determined by pulmonary function and MRC dyspnoea 
grade; multiple regression equation containing FEV, and dyspnoea accounted for 76% of the variance in 
Wmax (% predicted) ( Wmax= - 7.9 dysp+ l.lFEVi, +24). Exercise dyspnoea, assessed by the Borg 
scale, showed a significant linear correlation with minute ventilation. (i/~), maximal voluntary venti- 
lation (MVV) (%) (r=0.76; PcO.001). Medical Research Council dyspnoea score correlated relatively 
poorly with FEV, (% predicted) (Y= - 0.17; n.s.) and IVC (% predicted) (Y= - 0.48; n.s.). Borg score at 
maximal exercise did not correlate with MRC dyspnoea score (Y= - 0.07). Borg,,, score correlated 
significantly with MRC dyspnoea score (r=0.61; PcO.05). 
These results show that dyspnoea has an influence on exercise capacity. Dyspnoea score showed a 
large inter-individual variation, not strongly related to pulmonary function. It is concluded that 
dyspnoea deserves more attention in CF patients and needs to be assessed in rehabilitation programmes 
and other intervention studies in these patients. 
RESPIR. MED. (1997) 91, 4x-46 
Introduction 
In patients with cystic fibrosis (CF), the median 
age of survival has improved considerably (1). 
Despite this increase in expected life years, a 
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progressive decrease in exercise capacity is still 
a major problem for many patients. Limitation 
in exercise capacity has been ascribed to de- 
terioration in pulmonary function leading to a 
decreased ventilatory capacity, and also to mal- 
nutrition, which leads to a loss in muscle 
strength (2-6). Effects of exercise rehabilitation 
programmes have traditionally been evaluated 
by exercise capacity and pulmonary function 
(3,7,8). In contrast to patients with chronic 
obstructive pulmonary disease (COPD), where 
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recent research has focused on the impact of the 
disease on patients’ disability such as dyspnoea 
and exercise tolerance (g-12), little attention is 
paid to this subject in CF patients. In COPD 
patients, the substantial impact of dyspnoea on 
patients’ quality of life has been reported in 
several studies (9,11,13,14). Dyspnoea, and 
therefore fear of dyspnoea during activity, seems 
to play an important role in physical decon- 
ditioning in COPD patients (15,16). Dyspnoea 
may lead to avoidance of activity and patients 
run into a debilitative cycle (17,lS). Mahler et al. 
(9) reported that measurement of dyspnoea can 
be useful in the evaluation and care of patients 
with other chronic disease. 
The purpose of the present study was to 
examine the relationships between dyspnoea, 
exercise capacity and pulmonary function in 
patients with CF. 
Patients and Methods 
PATIENTS 
Fourteen patients with CF, referred for a routine 
ergometry test, were asked to participate in this 
study. No patients refused to participate. All 
patients were older than 16 years and had recur- 
rent respiratory tract infections and persistent 
cough. All patients provided written informed 
consent. The study was approved by the Medical 
Ethics Committee of the University Hospital. 
METHODS 
Exercise capacity, pulmonary function and dys- 
pnoea were assessed in each patient during a 
clinically stable period. Inspiratory vital capacity 
(IVC) and forced expiratory volume in 1 s 
(FEV,) were measured using a water-sealed 
spirometer (Lode). Predicted values of Quanjer 
were used to express pulmonary function % 
predicted values (19). Maximal voluntary venti- 
lation (MVV) was calculated from 35 x FEV,. 
Exercise tolerance was assessed using an auto- 
matic bicycle ergometry equipment (Jaeger EOS 
sprint) during continuous ECG recording. Each 
subject exercised continuously (pedal speed: 
60 rpm) with an initial work load of 0 W, which 
was increased every 3 min by 20 W. Heart rate 
(HR), breathing frequency. (BF), minute venti- 
lation ( VE), oxygen uptake (VO,) and carbon diox- 
ide production (PCO,) were measured continu- 
ously. The test was terminated by the patient’s 
symptoms or, if necessary, at the physician’s dis- 
cretion (i.e. decline in blood pressure, ECG 
changes, attainment of a given heart rate) (20). The 
maximal work load was defined as the highest load 
which could be reached and maintained for at least 
1.5 min. Maximum exercise capacity ( Wmax) 
expressed as the percentage of the predicted 
maximum exercise capacity using the equation of 
Wasserman et al. (21) was used for analysis. 
Before exercise and during the last 10 s of each 
work level, patients were asked to rate the sub- 
jective degree of dyspnoea using the modified 
Borg scale (22). This category scale is an indi- 
cator of the intensity of dyspnoea. The scale 
ranges from 0 to 10 where a value of 0 represents 
‘nothing at all’ and a value of 10 denotes that the 
intensity of dyspnoea is maximal. The Borg scale 
shown to patients was printed on a sheet of paper 
after a standard set of instructions (16). Borg 
scores at work levels representing 25% (Borg,,,) 
and 50% (Borg,,,O) of maximal work load, and 
maximal Borg scores (Borg,,,) were used for 
statistical analysis. 
Moreover, the Dutch version of the Medical 
Research Council (MRC) dyspnoea scale was used 
to rate limitation in function due to dyspnoea (23) 
(Table 1). This scale is based on six grades with 
regard to dyspnoea during various physical activi- 
ties and during rest. To grade dyspnoea with the 
MRC scale, patients were interviewed by asking 
questions concerning the patient’s symptoms 
according to the instructions reported by Van der 
Lende et al. (24). A higher MRC grade indicates 
more impairment due to dyspnoea. 
Statistical analysis was performed using the 
‘Statistical Package for the Social Sciences’ 
(SPSS-PC’) (25). Distribution of the variables 
was tested using the Kolmogorov-Smirnov 
Goodness of Fit test. Data were not significantly 
different from the normal distribution. Pearson’s 
r-test was used to examine the relation of pulmon- 
ary function and exercise capacity. Spearman’s 
rank-order correlation coefficients were deter- 
mined between ordinal dyspnoea ratings and 
physiological parameters. Stepwise multiple re- 
gression analysis with all physiologic variables and 
dyspnoea scores was performed to build a model 
to predict maximum exercise capacity. A P value 
~0.05 was considered statistically significant. 
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TABLE 1. Dutch version of the Medical Research Council dyspnoea scale 
Grade Description 
No=1 Are you troubled with breathlessness when hurrying on the level, walking up a 
Yes = continue slight hill, or going upstairs at normal pace? 
No=2 Are you troubled with breathlessness when walking with people of the same 
Yes =continue age at normal pace on the level? 
No=3 Do you have to stop for breath when walking at own pace on the level? 
Yes=continue 
No=4 Do you become short of breath at rest? 
Yes=continue 
Sometimes = 5 Sometimes or all the time? 
All the time=6 
Results 
Anthropometric data, pulmonary function, exer- 
cise capacity and MRC dyspnoea grade are pre- 
sented in Table 2. These results represent a 
TABLE 2. Anthropometric data, pulmonary function, 
exercise capacity and dyspnoea score of the cystic 
fibrosis patients in this study 
II= 14 Mean (SD) Range 
M/F 10/4 
Age (years) 25 (6.8) l&40 
Height (cm) 175 (7) 164-187 
Weight (kg) 59 (6) 49-7 1 
FEV, (1) 1.49 (0.68) 0.61-2.85 
FEV, (% predicted) 41 (19) 2@79 
IVC (1) 3.13 (1.01) 1.45-4.58 
IVC (% predicted) 63 (17) 33-90 
FEV,/IVC (%) 47 (10) 26-69 
MRC dyspnoea 2.5 (1.3) l-5 
Wmax (% predicted) 48 (28) O-79 
Maximal Borg score (n= 12) 6 (2) 3-10 
FEV,, forced expiratory volume in 1 s; FEV, (% 
predicted), FEV, as a percentage of the predicted 
value; IVC, inspiratory vital capacity; IVC (% pre- 
dicted), IVC as a percentage of the predicted value; 
FEVJIVC (%), FEV, as a percentage of IVC; Wmax 
(% predicted), maximal exercise capacity as a percent- 
age of the predicted value; MRC dyspnoea, Medical 
Research Council dyspnoea scale; Maximal Borg 
score, Borg score at maximum work load. 
spectrum from mild to severe CF based on pul- 
monary function data. Mean Wmax of the group 
was 48% predicted, but a wide range of values 
was noted. The latter was partly based on the fact 
that two patients were unable to perform the 
bicycle exercise test ( Wmax: 0% predicted). These 
patients demonstrated severe hypoxaemia at rest 
(SaO, less than 80%). During the exercise tests, 
the 12 other patients were considered to perform 
maximally according to usual criteria (20,26). 
FEV, (% predicted (Fig. 1) and IVC (% pre- 
dicted) showed a significant comparable cort-e- 
lation with exercise capacity (rz0.79 and O-77, 
respectively; PCO*OOl). 
Medical Research Council dyspnoea score was 
not significantly related to FEV, (% predicted) 
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FIG. 1. Relationship between FEV, (% predicted) 
and maximal exercise capacity ( Wmax, % pre- 
dicted). Pearson’s r correlation coefficient is 0.79; 
P~O~OOl. 
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FIG. 2. Relationship between FEV, (% predicted) 
and Medical Research Council dyspnoea score. 
Spear-man’s r correlation coefficient is - 0.17 (n.s.). 
(r= - 0.17; n.s.) and IVC (% predicted) 
(r= - O-48; ns.). It should be noted that one 
of the patients showed an extremely high 
MRC dyspnoea score in comparison to good 
pulmonary function (Fig. 2). 
The stepwise multiple regression equation 
indicated that FEV, and MRC dyspnoea score 
accounted for 76% of the variance in Wmax 
( Wmax= - 7*9dysp + l*lFEV, +24). FEV, was 
the dominant determining factor, but MRC dys- 
pnoea score contributed significantly to the 
model, increasing the explained variance in 
Wmax from 62 to 76%. 
Exercise dyspnoea, assessed by the Borg scale 
on each work level in 12 patients, showed 
a significant linear correlation with PE as a 
percentage of MW [ ~E/MVV(%)] (r = 0.76; 
P<O*OOl) (Fig. 3). Medical Research Council 
dyspnoea score correlated significantly with 
~E/MW (%) at rest (r=0*61; PcO.05). Borgmax 
score and Borg,,, score were not significantly 
correlated to MRC dyspnoea score (Y= - 0.07 
and t-=0*50, respectively), and Borg,,, score 
correlated significantly with MRC dyspnoea 
score (r=0*61; PcO.05). 
Discussion 
The present study investigated the relationship 
between dyspnoea scores, pulmonary function 
tests and exercise capacity in patients with CF. 
The patient group in this study showed a broad 
range in pulmonary function, exercise capacity 
data and dyspnoea scores. This study shows a 
good correlation between pulmonary function 
0 10 20 30 40 50 60 70 80 90 100 110 
VENVV 
FIG. 3. Relationship between minute ventilation 
(@/maximal voluntary ventilation (MVV) (%) and 
Borg score. Spearman’s r correlation coefficient is 
0.76; PcO*OOl. 
and exercise capacity. Medical Research Council 
dyspnoea score correlates relatively poorly with 
pulmonary function, but contributes signifi- 
cantly to the prediction of exercise capacity. 
Furthermore, exercise dyspnoea, assessed by the 
Borg scale, was closely related to the level of 
ventilation as expressed by PEIMVV ratio. 
Medical Research Council dyspnoea score was 
significantly related to Borg,,, score. 
Good correlations between exercise capacity 
and the degree of airway obstruction in CF 
patients have been reported by several other 
authors (2-6), suggesting a relationship between 
ventilatory capacity and limitation in exercise. 
This is supported by the present authors’ obser- 
vation of a ventilatory limitation to exercise in 
nine of the 12 patients who performed the bicycle 
test. In these patients, VE at maximal exercise was 
at least 89% of MVV, whereas healthy adults only 
utilize 70% of their MW during exercise (4), indi- 
cating that a ventilatory limit had been reached. 
Dyspnoea during daily living, as assessed by 
the MRC dyspnoea scale, and the perceived 
dyspnoea during the exercise test, assessed by 
the Borg scale on each work level, were related 
to the ventilation intensity as expressed by 
VE/MVV ratio. This finding is consistent with 
the results of other studies in patients with 
COPD (15,27). These results suggest that 
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perceived dyspnoea intensifies as ventilation 
increases in relation to maximum breathing 
capacity. At higher levels of ventilation, more 
work must be performed by the inspiratory 
muscles and this probably contributes to devel- 
opment of dyspnoea (2829). 
The present study found that in CF patients, 
pulmonary function values did not correlate 
significantly with limitation in function due to 
dyspnoea, as assessed by the MRC dyspnoea 
scale. It should be noted that the lack of a 
significant correlation between these parameters 
might be due to lack of statistical power. The 
number of CF patients studied (14 patients) 
might be too small to reveal statistically signifi- 
cant differences. In addition, it should be noted 
that one of the patients showed an extremely 
high MRC dyspnoea score in comparison to 
good pulmonary function. Statistical analysis 
without this outlier showed a significant rela- 
tionship between FEV, (% predicted) and 
MRC dyspnoea score (Y= - 0.58; P=O*O35). 
Previous data in patients with COPD regarding 
the correlation between pulmonary function 
and MRC dyspnoea score reveal contradictory 
results. Mahler et al. (9,lO) showed that the 
clinical rating of dyspnoea was significantly 
related to results of pulmonary function tests, 
illustrating their common clinical observation 
that patients with reduced pulmonary function 
experience more dyspnoea. On the other hand, 
the reported moderate association between pul- 
monary function and MRC scores (r values 
about O-45) implies a small explained variance 
in pulmonary function due to dyspnoea (about 
16%). Jones considered the correlations 
between spirometry results and dyspnoea 
measures as weak in patients with chronic dis- 
eases of the airways (11). According to this, in 
COPD patients as well as in CF patients, limi- 
tation in function due to dyspnoea is not 
strongly related to severity of airway obstruc- 
tion. This variability between individuals in the 
perception of dyspnoea is possibly related to 
psychologic factors. Illness behaviour of the 
patients could be an intermediating, but 
important, factor between pathophysiological 
processes, measured by spirometry and per- 
ceived dyspnoea during physical activity. The 
ascribed high score of MRC dyspnoea in 
comparison to good pulmonary function in 
one patient could be considered as an ex- 
treme example of this individual perception of 
dyspnoea. 
Maximal Borg score and MRC dyspnoea 
score were not significantly correlated. This can 
be explained by the fact that MRC dyspnoea 
score and maximal Borg score provide different 
information about the problem of dyspnoea. 
The MRC dyspnoea scale is a clinical rating 
scale used to measure the impact of dyspnoea 
on various components of daily living, and 
therefore does not address situations of maxi- 
mal exercise. The authors hypothesized that 
low to moderate work loads might be compar- 
able to the level of daily physical activities as 
earlier suggested by Marcotte et al. (2). Dysp- 
noea scores at low to moderate work loads 
might therefore be comparable to dyspnoea 
scores during daily living. Therefore, the 
present study compared Borg scores at work 
levels representing 25% (Borg,,,) and 50% 
(Borg,,,) of maximal work load with MRC 
dyspnoea score. The described correlation 
between Borg,,, score and MRC dyspnoea 
score confirms this hypothesis. 
Pulmonary function accounted for the great- 
est proportion of variance in exercise capacity. 
Independent of this effect of pulmonary func- 
tion, MRC dyspnoea grade had a significant 
effect on exercise capacity. This is in agreement 
with studies in COPD patients, where the rela- 
tion between clinical dyspnoea scores and 
exercise performance has also been shown to be 
good (11,30). 
In conclusion, this study shows that dyspnoea 
has an influence on exercise performance. 
Dyspnoea score showed a large inter-individual 
variation, not strongly related to pulmonary 
function. Additional studies should focus on the 
influence of reduction of dyspnoea on exercise 
capacity. Dyspno.ea scores should be used as an 
outcome parameter, in addition to exercise 
capacity, pulmonary function and quality of life, 
to evaluate the effect of exercise training in 
patients with CF. 
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